HALOZYME THERAPEUTICS INC (HALO:NASDAQ)
$76.2 -2.42 (-3.0781%)
Analysed HALOZYME THERAPEUTICS INC (HALO:NASDAQ) News Sources
Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today
04-06-2026
yahoo.com
How New ENHANZE Data And Analyst Support At Halozyme Therapeutics (HALO) Has Changed Its Investment Story
04-06-2026
yahoo.com
Halozyme Therapeutics (HALO) Up 0.8% Since Last Earnings Report: Can It Continue?
10-06-2026
yahoo.com
Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
15-06-2026
yahoo.com
2 Profitable Stocks Worth Your Attention and 1 We Question
18-06-2026
yahoo.com
ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?
25-06-2026
yahoo.com
Incyte (INCY) Surges 5.8%: Is This an Indication of Further Gains?
29-06-2026
yahoo.com
Halozyme Appoints David Ramsay as President Drug Delivery
30-06-2026
yahoo.com
1 Surging Stock for Long-Term Investors and 2 We Brush Off
01-07-2026
yahoo.com
2 Reasons to Like HALO and 1 to Stay Skeptical
10-07-2026
yahoo.com
What is the current price of HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The current price of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is $76.2.
HALOZYME THERAPEUTICS INC (HALO:NASDAQ) absolute price change since previous trading day?
The absolute price change of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) since the previous trading day is $-2.42.
HALOZYME THERAPEUTICS INC (HALO:NASDAQ) percentage price change since previous trading day?
The percentage price change of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) since the previous trading day is -3.0781%.
What is the most recent average sentiment score for HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The most recent average sentiment score for HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The most recent sentiment for HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is .
SEC-8K** Filing Available For HALOZYME THERAPEUTICS INC (HALO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.